Head-to-head comparisons of medication uses, side effects, warnings, and more.
Remicade (infliximab)
Rinvoq (upadacitinib)
Remicade (infliximab)
Rinvoq (upadacitinib)
Summary of Remicade vs. Rinvoq
Summary for Biologic DMARD
Prescription only
Remicade (infliximab) is an injectable medication used to treat many autoimmune conditions, including ulcerative colitis and Crohn's disease. It's given through an intravenous (IV) infusion by a healthcare provider.
Summary for JAK inhibitor
Prescription only
Rinvoq (upadacitinib) is a Janus kinase (JAK) inhibitor. It's used to treat certain inflammatory conditions, such as rheumatoid arthritis (RA), ulcerative colitis (UC), and eczema (atopic dermatitis). But it's not a first-choice option and typically only prescribed when other treatments haven't worked well. Rinvoq (upadacitinib) is taken by mouth, usually once daily. It's available as an extended-release tablet (Rinvoq) and an oral solution (Rinvoq LQ), but the two formulations aren't interchangeable. Side effects include a higher risk of infections, acne, and nausea.
Indications of Remicade vs. Rinvoq
Indications for
•Moderate-to-severe Crohn's disease (CD)
•Moderate-to-severe ulcerative colitis (UC)
•Moderate-to-severe rheumatoid arthritis (RA)
•Ankylosing spondylitis (AS)
•Psoriatic arthritis (PsA)
•Severe plaque psoriasis (PsO)
Indications for
Moderate-to-severe inflammatory conditions in which other treatments haven't worked: